This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Kidney and Renal Pelvic Cancer
  • /
  • Cabozantinib versus Everolimus in Advanced Renal-C...
Journal

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.

Read time: 1 mins
Published:5th Nov 2015
Author: Choueiri TK, Escudier B, Powles T, Mainwaring PN, Rini BI, Donskov F et al.
Availability: Free full text
Ref.:N Engl J Med. 2015 Nov 5;373(19):1814-23.
DOI:10.1056/NEJMoa1510016.
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest